ACCURAY INC

ARAY Nasdaq CIK: 0001138723

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1240 DEMING WAY, MADISON, WI, 53717
Mailing Address 1240 DEMING WAY, MADISON, WI, 53717
Phone 608-824-2800
Fiscal Year End 0630
EIN 208370041

Financial Overview

FY2025

-$1.59M
Net Income
$81.17M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 9, 2026 View on SEC
8-K Current report of material events February 6, 2026 View on SEC
8-K Current report of material events February 4, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) January 30, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
4 Insider stock transaction report January 9, 2026 View on SEC
8-K Current report of material events December 31, 2025 View on SEC
8-K Current report of material events December 16, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC

Material Events

8-K Other February 9, 2026
High Impact
  • Accuray emphasizes errors do not affect reported revenue, net income, or cash flows for any period.
  • The issue is limited to a specific footnote disclosure concerning 'remaining performance obligations' (RPO), not core financial performance.
View Analysis
8-K Financial Distress February 6, 2026
High Impact
  • Accuray develops advanced radiation therapy systems for cancer treatment.
  • Company is actively evaluating options and intends to regain Nasdaq compliance.
View Analysis
8-K Financial Distress December 16, 2025
High Impact
  • ACCURAY INC renegotiated important loan agreements and granted lenders options to buy company stock (warrants).
  • The changes provide the company with more financial flexibility and breathing room, including delayed financial health checks until end of 2026.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.